Abstract
Recurrent cervical cancer is a difficult challenge for gynecological oncologist. In this paper we review papers concerning incidence and surgical treatment of pelvic recurrences. A point of interest is studies evaluating completion surgery after radiotherapy/chemoradiotherapy. Surgery after definitive radiotherapy is associated with high morbidity and should be performed only in patients with residual tumor. Magnetic resonance imaging in special regimen can be useful in detecting residual disease.
Highlights
Recurrent cervical cancer is a difficult challenge for gynecological oncologist
In this paper we review papers concerning incidence and surgical treatment of pelvic recurrences
Surgery after definitive radiotherapy is associated with high morbidity and should be performed only in patients with residual tumor
Summary
Recurrent cervical cancer is a difficult challenge for gynecological oncologist. In this paper we review papers concerning incidence and surgical treatment of pelvic recurrences. Основной причиной летальности после лучевой терапии (ЛТ) местно-распространенного рака шейки матки (РШМ) являются локальные рецидивы, развивающиеся у 30–50 % всех пролеченных пациенток даже при видимом первичном эффекте лечения. У большинства пациенток развился центральный или латеральный тазовый рецидив, в основном в первые 2 года после завершения лечения. ––центральный или латеральный тазовый рецидив у пациенток после хирургического лечения без адъювантного облучения;
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.